up of acquired Cytyc and Third Wave inventory sold during fiscal
(2) To exclude the on-going, non-cash amortization of the intangible
assets acquired since fiscal 2006.
(3) To exclude the stock-based compensation associated with the
termination of former Third Wave executives in the fourth quarter of
(4) To exclude stock-based compensation related to the acceleration of
vesting and the modification of the terms of certain equity awards as
a result of the merger with Cytyc in the first quarter of fiscal
(5) To exclude the non-cash expense associated with the write-off of the
acquired in-process research and development related to the
merger with Cytyc and acquisition of Third Wave in fiscal 2008.
(6) To exclude restructuring charges consisting of cash and stock-based
compensation related to the resignation of the Company's Executive
Chairman in May 2008.
(7) To exclude the non-cash expense associated with the write-off of
certain intangible assets acquired from Cytyc in the first fiscal
quarter of 2008.
(8) To reflect an estimated effective tax rate of 36.8% on a non-GAAP
(9) To reflect an estimated effective tax rate of 36.3% on a non-GAAP
(10) Non-GAAP diluted earnings per share was calculated based on 259,242
and 250,569 weighted average diluted shares outstanding for the three
and twelve months ended September 27, 2008, respectively.
Non-GAAP Financial Guidance:
This press release also includes estimates of future non-GAAP adjusted
earnings and earnings per share. A reconciliation of these amounts to
expected GAAP results is presented below:
|SOURCE Hologic, Inc.|
Copyright©2008 PR Newswire.
All rights reserved